Suvomipic
Pharmaceutical compound
Suvomipic is a drug acting as a mitochondrial pyruvate carrier (MPC) inhibitor which is under development for the treatment of alopecia, specifically androgenic alopecia.
Pharmaceutical compound
Suvomipic is a drug acting as a mitochondrial pyruvate carrier (MPC) inhibitor which is under development for the treatment of alopecia, specifically androgenic alopecia.
Pharmaceutical compound
Nobody has pulled this card yet. The first copy makes you its discoverer.
Suvomipic is a drug acting as a mitochondrial pyruvate carrier (MPC) inhibitor which is under development for the treatment of alopecia, specifically androgenic alopecia. It is used topically as a 0.05% concentration gel on the scalp once-daily. Suvomipic is a possible first-in-class drug with a novel mechanism of action in the potential treatment of hair loss. The drug's generic name and chemical structure were published in July 2026, revealing PP405 to be the existing compound JXL069.
No sale yet.
None on the Market right now.